.svg){kind=small}
Samarjit Singh BSC, MSC
Director of Clinical Operations
Samarjit has been part of the Richmond Pharmacology team over 16 years, during which he held several positions, including his current role as Director of Clinical Operations.
Samarjit brings his years of industry experience and knowledge to drive best practice in (non-medical) clinical operations execution across the company, setting strategic guidance for the clinical operations teams and providing operational direction for the delivery of clinical trials undertaken at Richmond Pharmacology.
-min.jpg)
.jpg)
Latest news
Richmond enrols first patients in Verve Therapeutic’s Heart-2 trial - pioneering a new approach to cardiovascular disease
June 27, 2024
Richmond enrols and doses the first patient in a clinical trial aimed at transforming the care of cardiovascular disease with single treatment gene-editing medicines.
Read moreA first of a kind trial in the fight against malaria
June 12, 2024
Richmond successfully recruits and enrols adults of sub-Saharan ancestry who all complete a first of its kind trial in the treatment of malaria.
Read moreEvents
AHA Hypertension Scientific Sessions 2024
5 - 8 September 2024
Dr. Jörg Taubel, CEO of Richmond Pharmacology, will be attending the Hypertension 2024 Scientific Sessions
View event
